FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285588181> ?p ?o ?g. }

• W4285588181 endingPage "12" @default.
• W4285588181 startingPage "1" @default.
• W4285588181 abstract "Objective. circ_SFMBT2 was reported to facilitate malignant progression in various cancers, but its function in non-small-cell lung cancer (NSCLC) has not been fully uncovered. This study aimed to investigate the effects of N6-methyladenosine (m6A) methylation of circ_SFMBT2 (circ_0017628) on non-small-cell lung cancer (NSCLC) and its underlying mechanisms. Methods. Paired tumor and noncancerous tissues from NSCLC patients were surgically collected from January 2020 to March 2021 in our hospital. The levels of circ_SFMBT2 and LATS2 in NSCLC and human bronchial epithelial cells were assayed with qRT-PCR. Overexpression or silencing of circ_SFMBT2, LATS2, or YTHDF2 was performed in the NSCLC cells. CCK-8, colony-forming, and transwell assays were performed to analyze cell proliferation, viability, and migration, respectively. Meanwhile, the expression of MMP-9, E-cadherin, vimentin, and the Hippo/YAP pathway components was examined by western blotting. The m6A enrichment in circ_SFMBT2 was verified using methylated RNA immunoprecipitation, and interaction between circ_SFMBT2 and YTHDF2 was assessed by RNA pull-down and immunoprecipitation assays. Results. Both circ_SFMBT2 and LATS2 were lowly expressed in NSCLC cells and tissues. A positive correlation of circ_SFMBT2 with LATS2 was identified, and circ_SFMBT2 was localized predominantly in the cytoplasm. circ_SFMBT2 overexpression negatively regulated cell proliferation, viability, migration, and epithelial-mesenchymal transition while promoting the Hippo/YAP pathway activation. Notably, knockdown of LATS2 effectively abrogated the inhibitory effects of circ_SFMBT2 overexpression on NSCLC cell malignancies. Besides, m6A was specifically enriched in circ_SFMBT2, and circ_SFMBT2 could bind to YTHDF2. Silencing of YTHDF2 led to an increase in circ_SFMBT2 expression while inhibiting the malignancy of cancer cells. Conclusion. Our results showed that YTHDF2 could facilitate NSCLC cell proliferation and metastasis via the Hippo/YAP pathway activation by mediating circ_SFMBT2 degradation." @default.
• W4285588181 created "2022-07-16" @default.
• W4285588181 creator A5008659038 @default.
• W4285588181 creator A5011597011 @default.
• W4285588181 creator A5016272038 @default.
• W4285588181 creator A5019366289 @default.
• W4285588181 creator A5049026507 @default.
• W4285588181 creator A5050027776 @default.
• W4285588181 creator A5080848371 @default.
• W4285588181 creator A5085616337 @default.
• W4285588181 creator A5086841250 @default.
• W4285588181 date "2022-07-16" @default.
• W4285588181 modified "2023-10-14" @default.
• W4285588181 title "N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation" @default.
• W4285588181 cites W1941339056 @default.
• W4285588181 cites W1967004871 @default.
• W4285588181 cites W1980850535 @default.
• W4285588181 cites W1989683090 @default.
• W4285588181 cites W1996690536 @default.
• W4285588181 cites W2003530231 @default.
• W4285588181 cites W2008920883 @default.
• W4285588181 cites W2054841768 @default.
• W4285588181 cites W2064165694 @default.
• W4285588181 cites W2272984102 @default.
• W4285588181 cites W2280957887 @default.
• W4285588181 cites W2554087867 @default.
• W4285588181 cites W2601436215 @default.
• W4285588181 cites W2752229407 @default.
• W4285588181 cites W2781327172 @default.
• W4285588181 cites W2783721398 @default.
• W4285588181 cites W2794616841 @default.
• W4285588181 cites W2900684524 @default.
• W4285588181 cites W2913336364 @default.
• W4285588181 cites W2952883401 @default.
• W4285588181 cites W2963850569 @default.
• W4285588181 cites W2981014677 @default.
• W4285588181 cites W2984672214 @default.
• W4285588181 cites W2999417355 @default.
• W4285588181 cites W3009589044 @default.
• W4285588181 cites W3088917709 @default.
• W4285588181 cites W3191441300 @default.
• W4285588181 cites W3200762156 @default.
• W4285588181 doi "https://doi.org/10.1155/2022/1087622" @default.
• W4285588181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35924072" @default.
• W4285588181 hasPublicationYear "2022" @default.
• W4285588181 type Work @default.
• W4285588181 citedByCount "3" @default.
• W4285588181 countsByYear W42855881812023 @default.
• W4285588181 crossrefType "journal-article" @default.
• W4285588181 hasAuthorship W4285588181A5008659038 @default.
• W4285588181 hasAuthorship W4285588181A5011597011 @default.
• W4285588181 hasAuthorship W4285588181A5016272038 @default.
• W4285588181 hasAuthorship W4285588181A5019366289 @default.
• W4285588181 hasAuthorship W4285588181A5049026507 @default.
• W4285588181 hasAuthorship W4285588181A5050027776 @default.
• W4285588181 hasAuthorship W4285588181A5080848371 @default.
• W4285588181 hasAuthorship W4285588181A5085616337 @default.
• W4285588181 hasAuthorship W4285588181A5086841250 @default.
• W4285588181 hasBestOaLocation W42855881811 @default.
• W4285588181 hasConcept C104317684 @default.
• W4285588181 hasConcept C119056186 @default.
• W4285588181 hasConcept C121608353 @default.
• W4285588181 hasConcept C142724271 @default.
• W4285588181 hasConcept C147447768 @default.
• W4285588181 hasConcept C1491633281 @default.
• W4285588181 hasConcept C172512520 @default.
• W4285588181 hasConcept C173396325 @default.
• W4285588181 hasConcept C185592680 @default.
• W4285588181 hasConcept C203014093 @default.
• W4285588181 hasConcept C204232928 @default.
• W4285588181 hasConcept C2776256026 @default.
• W4285588181 hasConcept C2779013556 @default.
• W4285588181 hasConcept C502942594 @default.
• W4285588181 hasConcept C54355233 @default.
• W4285588181 hasConcept C55493867 @default.
• W4285588181 hasConcept C62112901 @default.
• W4285588181 hasConcept C71924100 @default.
• W4285588181 hasConcept C76419328 @default.
• W4285588181 hasConcept C81885089 @default.
• W4285588181 hasConcept C86803240 @default.
• W4285588181 hasConceptScore W4285588181C104317684 @default.
• W4285588181 hasConceptScore W4285588181C119056186 @default.
• W4285588181 hasConceptScore W4285588181C121608353 @default.
• W4285588181 hasConceptScore W4285588181C142724271 @default.
• W4285588181 hasConceptScore W4285588181C147447768 @default.
• W4285588181 hasConceptScore W4285588181C1491633281 @default.
• W4285588181 hasConceptScore W4285588181C172512520 @default.
• W4285588181 hasConceptScore W4285588181C173396325 @default.
• W4285588181 hasConceptScore W4285588181C185592680 @default.
• W4285588181 hasConceptScore W4285588181C203014093 @default.
• W4285588181 hasConceptScore W4285588181C204232928 @default.
• W4285588181 hasConceptScore W4285588181C2776256026 @default.
• W4285588181 hasConceptScore W4285588181C2779013556 @default.
• W4285588181 hasConceptScore W4285588181C502942594 @default.
• W4285588181 hasConceptScore W4285588181C54355233 @default.
• W4285588181 hasConceptScore W4285588181C55493867 @default.
• W4285588181 hasConceptScore W4285588181C62112901 @default.
• W4285588181 hasConceptScore W4285588181C71924100 @default.

• next